Global immuno-oncology clinical trials market surges to projected USD 23.63 billion by 2032 with a staggering CAGR of 12.37%. What groundbreaking advancements are driving this exponential growth in cancer research and treatment? Stay tuned for the unexpected twist that could revolutionize precision oncology as we know it.